Industry Educational Session - Sponsored and promoted by Novartis: Putting Patients First in CML: Quality of Life, Optimised Therapy and Switching Strategies post-ELN Guidelines - Sponsored by Novartis
Tracks
-
| Tuesday, April 21, 2026 |
| 12:30 PM - 1:15 PM |
| Room 4, Upper Level |
Details
This promotional symposium is organised and funded by Novartis Pharmaceuticals UK, Ltd. intended for UK healthcare professionals only. Prescribing Information will be available at the meetings for all Novartis brands mentioned.
Relevant Prescribing Information and Adverse Event Statement will be available at the meeting
Join Dr Kate Rothwell, Kirsty Crozier, and Nick Duncan for a live, case‑based MDT lunchtime session for CML‑treating HCPs. This interactive discussion uses real‑world cases to showcase how the MDT work together to build a holistic picture of each patient’s needs—clinical, practical, and quality‑of‑life.
Through an interactive session, we will focus on recognising TKI‑related QoL challenges that impact daily life, spotting triggers for treatment review, and navigating the complexities of patient management. We’ll highlight how nurses and pharmacists uncover day‑to‑day impact and support symptom management, how to strengthen patient education, and how to use clinical and patient‑reported data to support shared decision‑making.
UK | FA-11598259 | March 2026
Speaker
Dr. Kate Rothwell
Consultant
Leeds Teaching Hospitals NHS Trust
Speaker One
Consultant Haematology, CML and MDT lead at Calderdale and Huddersfield NHS Foundation Trust
Mr Nick Duncan
Consultant Haematology Pharmacist
UHB NHS Foundation Trust
Speaker Two
Consultant Pharmacist at University Hospitals Birmingham NHS Foundation Trust
Kirsty Crozier
NHS/University of Oxford
Speaker Three
Consultant Nurse at The Great Western Hospital and Lead Academic Research Nurse at University of Oxford